close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

MDT

86.54

-2.25%↓

A

121.03

-0.24%↓

VEEV

165.33

+3.83%↑

HQY

83.09

+3.06%↑

NEOG

9.51

+0.85%↑

MDT

86.54

-2.25%↓

A

121.03

-0.24%↓

VEEV

165.33

+3.83%↑

HQY

83.09

+3.06%↑

NEOG

9.51

+0.85%↑

MDT

86.54

-2.25%↓

A

121.03

-0.24%↓

VEEV

165.33

+3.83%↑

HQY

83.09

+3.06%↑

NEOG

9.51

+0.85%↑

MDT

86.54

-2.25%↓

A

121.03

-0.24%↓

VEEV

165.33

+3.83%↑

HQY

83.09

+3.06%↑

NEOG

9.51

+0.85%↑

MDT

86.54

-2.25%↓

A

121.03

-0.24%↓

VEEV

165.33

+3.83%↑

HQY

83.09

+3.06%↑

NEOG

9.51

+0.85%↑

Home・Aandelen Lijst・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorGezondheidszorg

8.49 1.43

Strong Buy

Prijsupdate 15 apr 2026, 16:15 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.28

Max

8.54

Belangrijke statistieken

By Trading Economics

Inkomsten

-69M

-102M

Verkoop

-10M

34M

EPS

-5.69

Winstmarge

-299.886

Werknemers

228

EBITDA

4.7M

-18M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+81.16% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-15M

142M

Vorige openingsprijs

7.06

Vorige sluitingsprijs

8.49

Nieuwssentiment

By Acuity

50%

50%

156 / 348 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

5.9501 / 7.66 Steun & Weerstand

Karyopharm Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 apr 2026, 23:36 UTC

Acquisities, Fusies, Overnames

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion -- Update

DJ

Lezen

14 apr 2026, 23:24 UTC

Populaire aandelen

Stocks to Watch: Gloo, Broadcom, GitLab

DJ

Lezen

14 apr 2026, 22:42 UTC

Acquisities, Fusies, Overnames

China-Backed Yancoal Australia to Buy Kestrel Coal Mine Stake For Up to $2.4 Billion

DJ

Lezen

14 apr 2026, 21:32 UTC

Belangrijke Marktbewegers

GitLab Shares Rise on Expanded Google Cloud Collaboration

DJ

Lezen

14 apr 2026, 23:54 UTC

Marktinformatie

Nikkei May Rise as Fears About Energy Shortage Ease -- Market Talk

DJ

Lezen

14 apr 2026, 23:34 UTC

Marktinformatie

Gold Edges Lower on Possible Technical Correction -- Market Talk

DJ

Lezen

14 apr 2026, 22:54 UTC

Winsten

BRP: Amendment Mainly Leads to 25% Tariff on Total Value of Imported Snowmobiles and Majority of ORV Models, Replacing Previous 50% Tariff on Applicable Metal Content Only >DOO.T

DJ

Lezen

14 apr 2026, 22:54 UTC

Winsten

BRP: Suspending Guidance Following Amendment of Section 232 Tariffs on Steel, Aluminum and Copper Imports Into U.S., Which Came Into Effect on April 6 >DOO.T

DJ

Lezen

14 apr 2026, 22:54 UTC

Winsten

BRP: Currently Estimates Potential Incremental Tariff Cost Related to This Amendment in Excess of $500M for Remainder of Yr >DOO.T

DJ

Lezen

14 apr 2026, 22:54 UTC

Winsten

BRP: Suspends FY27 Guidance Due to Changes to U.S. Tariff Environment

DJ

Lezen

14 apr 2026, 22:17 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: Targets Deal Completion Toward End of 3Q

DJ

Lezen

14 apr 2026, 22:17 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: Acquisition Diversifies Portfolio; Met Coal Share to Rise to 22%

DJ

Lezen

14 apr 2026, 22:17 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: Asset 'Strong Strategic Fit'; to Positively Add Production, Cash Flow

DJ

Lezen

14 apr 2026, 22:16 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: Intends to Fund Acquisition With Cash, 5-Year Loan Facility

DJ

Lezen

14 apr 2026, 22:15 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: Contingent Consideration Linked to Average Annual Prices For 5 Years

DJ

Lezen

14 apr 2026, 22:14 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: Deal Includes Contingent Cash Consideration Up to $550 Million

DJ

Lezen

14 apr 2026, 22:13 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: Deal Includes $1.85 Billion Upfront Consideration

DJ

Lezen

14 apr 2026, 22:12 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: To Buy Kestrel Stake From EMR Capital, Adaro Capital

DJ

Lezen

14 apr 2026, 22:12 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: To Buy Kestrel Stake For Up to $2.4 Billion

DJ

Lezen

14 apr 2026, 22:10 UTC

Acquisities, Fusies, Overnames

Yancoal Australia: to Acquire 80% Interest in Kestrel Coal Mine

DJ

Lezen

14 apr 2026, 20:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

DJ

Lezen

14 apr 2026, 20:33 UTC

Acquisities, Fusies, Overnames

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

DJ

Lezen

14 apr 2026, 20:32 UTC

Populaire aandelen

Stocks to Watch: JPMorgan, American Airlines, LVMH, BlackRock -- WSJ

DJ

Lezen

14 apr 2026, 19:59 UTC

Acquisities, Fusies, Overnames

Microsoft Is Buying 3,200 Acres For a Data Center. This Utility Stock Is Rising. -- Barrons.com

DJ

Lezen

14 apr 2026, 19:38 UTC

Winsten

Johnson & Johnson Financial Chief Sees 'Clear Line of Sight' to Double-Digit Growth by 2030 -- Barrons.com

DJ

Lezen

14 apr 2026, 19:27 UTC

Marktinformatie

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

DJ

Lezen

14 apr 2026, 19:21 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Oil Futures Retreat on Hopes for U.S.-Iran Peace Talks -- Market Talk

DJ

Lezen

14 apr 2026, 19:09 UTC

Acquisities, Fusies, Overnames

Apple and Amazon Partner on Satellite Deal. Why It Makes Sense. -- Barrons.com

DJ

Lezen

14 apr 2026, 18:30 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

14 apr 2026, 18:30 UTC

Marktinformatie

Treasury Yields, Dollar Fall as Markets Price Higher Odds of Fed Cuts -- Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

Karyopharm Therapeutics Inc Prognose

Koersdoel

By TipRanks

81.16% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 15 USD  81.16%

Hoogste 28 USD

Laagste 8 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Karyopharm Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Gebaseerd op 6 analisten die aandelenratings hebben gegeven aan Karyopharm Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

5.9501 / 7.66Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bearish Evidence

All events are bearish.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

156 / 348 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

MDT

Medtronic PLC

86.54

↓-2.25%

A

Agilent Technologies Inc

121.03

↓-0.24%

VEEV

Veeva Systems Inc

165.33

↑ +3.83%

HQY

HealthEquity Inc

83.09

↑ +3.06%

NEOG

Neogen Corp

9.51

↑ +0.85%
help-icon Live chat